The name that Republican tax writers gave to a new, multibillion-dollar business levy implies that it targets foreign earnings from "intangible" intellectual property—hitting tech firms and drugmakers like Apple and Pfizer.
But experts agree that the little understood "global intangible low-taxed income" levy, or GILTI, will also apply to earnings that go far beyond patents, royalties, and licensing, and could end up snaring many global firms that earn little such income. Private equity partnerships that aren't publicly traded, including Bain Capital, stand to pay rates three times as high as corporate competitors, tax lawyers say. Law and advertising firms with overseas offices may also be hit—as will many U.S. companies that make "excess" profit from foreign plants, equipment, and inventory.
The name is "Orwellian," James Duncan, a tax partner at the law firm Cleary Gottlieb Steen & Hamilton, said in a Dec. 20 webcast. "Its most significant effect is on income that is neither intangible nor low-taxed."
Complete your profile to continue reading and get FREE access to Treasury & Risk, part of your ALM digital membership.
Your access to unlimited Treasury & Risk content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Critical Treasury & Risk information including in-depth analysis of treasury and finance best practices, case studies with corporate innovators, informative newsletters, educational webcasts and videos, and resources from industry leaders.
- Exclusive discounts on ALM and Treasury & Risk events.
- Access to other award-winning ALM websites including PropertyCasualty360.com and Law.com.
*May exclude premium content
Already have an account? Sign In
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
